Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)
Elanco Animal Health's (ELAN) quarterly Asset Writedowns and Impairment came in at $47.0 million in Q4 2025, up 840.0% year-over-year from $5.0 million in Q4 2024, and up 95.83% quarter-over-quarter from $24.0 million in Q3 2025.
Analysis
Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends
Elanco Animal Health has disclosed Asset Writedowns and Impairment across 9 years of filings, most recently posting $47.0 million for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 840.0% year-over-year to $47.0 million; the TTM figure through Dec 2025 stood at $91.0 million (up 75.0% YoY), while the FY2025 annual figure was $71.0 million, down 12.35% from the prior year.
- Asset Writedowns and Impairment came in at $47.0 million for Q4 2025 at Elanco Animal Health, up from $24.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $275.0 million in Q2 2021 to a low of $5.0 million in Q4 2021.
- Average Asset Writedowns and Impairment over 5 years is $45.8 million, with a median of $23.0 million recorded in 2022.
- Year-over-year, Asset Writedowns and Impairment soared 9066.67% in 2021 and sank 81.48% in 2024.
- Over 5 years, Asset Writedowns and Impairment stood at $5.0 million in 2021, then soared by 1080.0% to $59.0 million in 2022, then plunged by 54.24% to $27.0 million in 2023, then sank by 81.48% to $5.0 million in 2024, then jumped by 840.0% to $47.0 million in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $47.0 million in Q4 2025, $24.0 million in Q3 2025, and $5.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 47.00 Mn |
| Sep 30, 2025 | 24.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Dec 31, 2023 | 27.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2022 | 59.00 Mn |
| Mar 31, 2022 | 22.00 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 56.00 Mn |
| Jun 30, 2021 | 275.00 Mn |
| Mar 31, 2021 | 9.00 Mn |
| Dec 31, 2020 | 20.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 3.00 Mn |
| Dec 31, 2019 | 8.30 Mn |
| Sep 30, 2019 | 10.20 Mn |
| Mar 31, 2019 | 4.00 Mn |
| Dec 31, 2018 | 18.00 Mn |
| Sep 30, 2018 | 6.20 Mn |